Cost-Effectiveness Of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Compared With Efavirenz/Emtricitabine/Tenofovir As First-Line Hiv Antiretroviral Therapy In The Adult Population In The United States
May 1, 2013, 00:00
10.1016/j.jval.2013.03.430
https://www.valueinhealthjournal.com/article/S1098-3015(13)00501-9/fulltext
Title :
Cost-Effectiveness Of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Compared With Efavirenz/Emtricitabine/Tenofovir As First-Line Hiv Antiretroviral Therapy In The Adult Population In The United States
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)00501-9&doi=10.1016/j.jval.2013.03.430
First page :
A92
Section Title :
Infection
Open access? :
No
Section Order :
1477